NeuroLite

NeuroLite is an investigational photobiomodulation device that delivers targeted near-infrared light therapy directly to brain tissue. This wearable system combines:

• Transcranial delivery: 810nm near-infrared LEDs targeting affected brain regions through the scalp

• Intranasal photobiomodulation: 650nm red light therapy via nasal cavity for enhanced brain penetration

• Non-invasive treatment: Comfortable, head-mounted design for home or clinical use

The device utilizes specific light wavelengths proven to penetrate skull tissue and stimulate cellular activity in areas commonly affected by Alzheimer’s disease and mild cognitive impairment.

Photobiomodulation therapy harnesses the power of specific light wavelengths to activate cellular processes within brain tissue. This low-level light therapy (LLLT) approach offers several mechanisms of action:

Mitochondrial Enhancement and ATP Production

• Cytochrome c oxidase activation: Near-infrared light stimulates this key enzyme in the mitochondrial respiratory chain
• Increased ATP synthesis: Enhanced cellular energy production supports neuronal function and survival
• Mitochondrial biogenesis: Light therapy may promote the formation of new mitochondria in brain cells

Neuroprotective Mechanisms

• Improved cerebral blood flow: Enhanced vascularization delivers oxygen and nutrients to brain tissue
• Reduced neuroinflammation: Light therapy modulates inflammatory responses associated with cognitive decline
• Oxidative stress reduction: Antioxidant pathways are upregulated, protecting neurons from damage
• Neuroplasticity promotion: Stimulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor

Clinical Benefits of NeuroLite Photobiomodulation Therapy

Research on transcranial photobiomodulation for cognitive impairment demonstrates multiple potential benefits:

Cognitive Function Improvements

• Memory enhancement: Working memory, episodic memory, and memory consolidation
• Attention and focus: Sustained attention and executive function capabilities
• Processing speed: Improved cognitive processing and reaction times
• Language function: Communication abilities and verbal fluency

Quality of Life Enhancements

• Sleep quality improvement: Better sleep patterns and reduced sleep disturbance
• Mood stabilization: Reduced depression and anxiety symptoms
• Behavioral symptom management: Decreased agitation and improved social interaction
• Caregiver burden reduction: Enhanced patient independence and communication

NeuroLite vs. Medications

Unlike pharmaceutical interventions, photobiomodulation therapy offers:

• Disease-modifying potential: May address underlying cellular dysfunction
• Complementary treatment: Can be used alongside existing medications
• Preventive applications: Potential for early intervention in mild cognitive impairment
• Personalized dosing: Treatment parameters can be adjusted based on individual needs

Who Can Benefit from NeuroLite Light Therapy?

NeuroLite photobiomodulation therapy may be appropriate for:

• Early-stage Alzheimer’s disease patients seeking adjunctive treatments
• Mild Cognitive Impairment (MCI) individuals looking for preventive interventions
• Vascular dementia patients with compromised cerebral blood flow
• Age-related cognitive decline in healthy aging populations
• Post-stroke cognitive impairment requiring neuroplasticity enhancement

Important Medical Disclaimer: NeuroLite is an investigational medical device. This content is for educational purposes only and does not constitute medical advice. Individual results may vary. Consult with qualified healthcare professionals before beginning any new treatment for Alzheimer’s disease, mild cognitive impairment, or other neurological conditions. Always follow your physician’s recommendations.